{"url_path":"/sec/tmdx/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-234440-index.html","accession_number":"0001193125-26-234440","cik":"0001756262","ticker":"TMDX","issuer_name":"TransMedics Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1756262/0001193125-26-234440-index.html","primary_entity_key":"0001756262","primary_entity_name":"TransMedics Group, Inc."},"word_count":97,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\n  \nDescription\n\n10.1\n  \n[Amendment No. 1 to Amended and Restated TransMedics Group, Inc. 2019 Stock Incentive Plan](d79022dex101.htm)\n\n104\n  \nThe cover page from this Current Report on Form 8-K, formatted in Inline XBRL\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nTRANSMEDICS GROUP, INC.\n\nDate: May 21, 2026\n \n\n \nBy:\n \n\n/s/ Matthew S. Forsyth\n\n \n\n \nName:\n \nMatthew S. Forsyth\n\n \n\n \nTitle:\n \nSenior Vice President, General Counsel & Corporate Secretary"}